MapLight Therapeutics (MPLT) Earnings Date & Reports
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MPLT is expected to report earnings to fall 7.58% to -122 cents per share on December 03
Q3'26
Est.
$-1.22
Q2'26
Missed
by $0.33
Q1'26
Missed
by $0.42
The last earnings report on August 13 showed earnings per share of -132 cents, missing the estimate of -99 cents. With 183.35K shares outstanding, the current market capitalization sits at 458.50M.